Frequency of potential interactions between drugs in medical prescriptions in a city in southern Brazil
Keywords:
Adult, Aged, Drug interactions, Pharmacoepidemiology, Prescriptions, drugAbstract
CONTEXT AND OBJECTIVE: Drug interactions form part of current clinical practice and they affect between 3 and 5% of polypharmacy patients. The aim of this study was to identify the frequency of potential drug-drug interactions in prescriptions for adult and elderly patients. TYPE OF STUDY AND SETTING: Cross-sectional pharmacoepidemiological survey in the Parque Verde housing project, municipality of Cascavel, Paraná, Brazil, between December 2006 and February 2007. METHODS: Stratified cluster sampling, proportional to the total number of homes in the housing project, was used. The sample consisted of 95 homes and 96 male or female patients aged 19 or over, with medical prescriptions for at least two pharmaceutical drugs. Interactions were identified using DrugDigest, Medscape and Micromedex softwares. RESULTS: Most of the patients were female (69.8%), married (59.4%) and in the age group of 60 years or over (56.3%), with an income less than or equal to three minimum monthly salaries (81.3%) and less than eight years of schooling (69.8%); 90.6% of the patients were living with another person. The total number of pharmaceutical drugs was 406 (average of 4.2 medications per patient). The drugs most prescribed were antihypertensives (47.5%). The frequency of drug interactions was 66.6%. Among the 154 potential drug interactions, 4.6% were classified as major, 65.6% as moderate and 20.1% as minor. CONCLUSION: The high frequency of drug prescriptions with a potential for differentiated interactions indicates a situation that has so far been little explored, albeit a reality in household surveys.
Downloads
References
Nies AS. Princípios da terapêutica. In: Gilman AG, Hardman JG, Limbird LE, organizers. Goo- dman & Gilmann: as bases farmacológicas da terapêutica. 10a ed. Rio de Janeiro: McGraw- Hill; 2003. p. 35-50.
Fonseca AL. Interações medicamentosas. 3a ed. Rio de Janeiro: EPUC; 2001.
Raschetti R, Morgutti M, Menniti-Ippolito F, et al. Suspected adverse drug events re- quiring emergency department visits or hospital admissions. Eur J Clin Pharmacol. 1999;54(12):959-63.
Becker ML, Caspers PW, Kallewaard M, et al. Determinants of potential drug-drug interac- tion associated dispensing in community pharmacies in the Netherlands. Pharm World Sci. 2007;29(2):51-7.
Katzung BG. Farmacologia básica e clínica. 9a ed. Rio de Janeiro: Guanabara Koogan; 2005.
Rang HP, Dale MN, Ritter JM, Moore PK. Farmacologia. 5a ed. Rio de Janeiro: Elsevier; 2004.
Marcolin MA, Cantarelli MG, Garcia Junior M. Interações farmacológicas entre medicações clínicas e psiquiátricas [Drug interactions among clinical and psychiatric drugs]. Rev Psi- quiatr Clin (São Paulo). 2004;31(2):70-81.
Miyasaka LS, Atallah AN. Risk of drug interaction: combination of antidepressants and other drugs. Rev Saúde Pública = J Public Health. 2003;37(2):212-5.
Vonbach P, Dubied A, Krähenbühl S, Beer JH. Evaluation of frequently used drug interaction screening programs. Pharm World Sci. 2008;30(4):367-74.
Cruciol-Souza JM, Thomson JC. Um estudo farmacoepidemiológico de interações medica- mentosas em um hospital universitário brasileiro [A pharmacoepidemiology study of drug interactions in a Brazilian teaching hospital]. Clinics. 2006;61(6):515-20.
Cahill JA. Responsibilities of physicians and pharmacists in preventing drug interactions. JAMA. 2002;287(5):586-7.
Brasil. Ministério do Planejamento, Orçamento e Gestão. Instituto Brasileiro de Geografia e Estatística. Estimativas populacionais para os municípios brasileiros em 01/07/2008. Available from: www.ibge.gov.br/home/estatistica/populacao/estimativa2008. Accessed in 2009 (Sep 2).
DrugDigest. Drug interaction 2007. Available from: www.drugdigest.org/wps/portal/ddi-gest. Accessed in 2007 (Aug 15).
Medscape. Drug information. Drug interaction 2007. Available from: http://www.medscape.com/. Accessed in 2007 (Aug 10).
Micromedex healthcare series 2008. Available from: www.periodicos.capes.gov.br. Accessed in 2008 (Apr 10).
World Health Organization. The anatomical therapeutic chemical classification system with defined daily doses (ATC/DDD). Available from: http://www.who.int/classifications/atcddd/en/. Accessed in 2009 (Sep 9).
Flores LM, Mengue SS. Uso de medicamentos por idosos em região do sul do Bra- sil [Drug use by the elderly in Southern Brazil]. Rev Saúde Pública = J Public Health. 2005;39(6):924-9.
Nóbrega OT, Melo GF, Karnikowski MGO. Pattern of drugs prescribed for community-residing middle-aged and older adults from the outskirts of Brasilia. RBCF Rev Bras Ciênc Farm (Impr). 2005;41(2):271-7.
Coelho Filho JM, Marcopito LF, Castelo A. Perfil de utilização de medicamentos por idosos em área urbana do Nordeste do Brasil [Medication use patterns among elderly people in urban area in Northeastern Brazil]. Rev Saúde Pública = J Public Health. 2004;38(4):557- 64.
Loyola Filho AI, Uchoa E, Firmo JOA, Lima-Costa MF. Estudo de base populacional sobre o consumo de medicamentos entre idosos: Projeto Bambuí [A population-based study on use of medications by elderly Brazilians: the Bambuí Health and Aging Study (BHAS)]. Cad Saúde Pública = Rep Public Health. 2005;21(2):545-53.
Doubova Dubova SV, Reyes-Morales H, Torres-Arreola Ldel P, Suárez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico city. BMC Health Serv Res. 2007;7:147.
Nobrega OT, Karnikowski MGO. A terapia medicamentosa no idoso: cuidados na medica- ção [Pharmacotherapy in the elderly: precautions with medication]. Ciênc Saúde Coletiva. 2005;10(2):309-13.
Jounela AJ, Lilja M. Interactions between beta-blockers and clonidine. Ann Clin Res. 1984;16(4):181-2.
Staff PDR. Drug information for the health care professional. 27th ed. Massachusetts: Thom- son Healthcare; 2006.
Weinfeld MS, Drazner MH, Stevenson WG, Stevenson LW. Early outcome of initiating amiodaro- ne for atrial fibrillation in advanced heart failure. J Heart Lung Transplant 2000;19(7):638-43.
DeVore KJ, Hobbs RA. Plasma digoxin concentration fluctuations associated with timing of plasma sampling and amiodarone administration. Pharmacotherapy. 2007;27(3):472-5.
Sanoski CA, Bauman JL. Clinical observations with the amiodarone/warfarin interaction: dosing relationships with long-term therapy. Chest. 2002;121(1):19-23.
Zhang K, Young C, Berger J. Administrative claims analysis of the relationship between warfa- rin use and risk of hemorrhage including drug-drug and drug-disease interactions. J Manag Care Pharm. 2006;12(8):640-8.
Lu Y, Won KA, Nelson BJ, Qi D, Rausch DJ, Asinger RW. Characteristics of the amiodarone-war- farin interaction during long-term follow-up. Am J Health Syst Pharm. 2008;65(10):947-52.
Moura CS, Ribeiro AQ, Magalhães SMS. Avaliação de interações medicamentosas potenciais em prescrições médicas do Hospital das Clínicas da Universidade Federal de Minas Gerais (Brasil). Lat Am J Pharm. 2007;26(4):596-601. Available from: http://www.latamjpharm.org/trabajos/26/4/LAJOP_26_4_4_3_L0B81ER36G.pdf. Accessed in 2009 (Sep 2).
